Terms: = Colorectal cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Diagnosis
40 results:
1. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
[No Abstract] [Full Text] [Related]
2. Causes of death in patients operated for colorectal cancer.
Sonal S; Boudreau C; Lee GC; Cauley CE; Kunitake H; Goldstone RN; Francone TD; Bordeianou LG; Ricciardi R; Berger DL
Surgery; 2024 May; 175(5):1285-1290. PubMed ID: 38378348
[TBL] [Abstract] [Full Text] [Related]
3. Systematic analyzing a five- miRNA panel and its diagnostic value of plasma expression in colorectal cancer.
Li SQ; Xie LY; Cai ZM; Wei HT; Xie MZ; Hu BL; Ning SF
Mol Biol Rep; 2023 Sep; 50(9):7253-7261. PubMed ID: 37418078
[TBL] [Abstract] [Full Text] [Related]
4. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in colorectal cancer.
Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
[TBL] [Abstract] [Full Text] [Related]
5. A bayesian approach to model the underlying predictors of early recurrence and postoperative death in patients with colorectal cancer.
Mahmoudi L; Fallah R; Roshanaei G; Asghari-Jafarabadi M
BMC Med Res Methodol; 2022 Oct; 22(1):269. PubMed ID: 36224555
[TBL] [Abstract] [Full Text] [Related]
6. Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis.
Huang Y; Zhang X; PengWang ; Li Y; Yao J
BMC Genom Data; 2022 Jun; 23(1):48. PubMed ID: 35733095
[TBL] [Abstract] [Full Text] [Related]
7. Mir-4746 inhibits the proliferation of colorectal cancer cells in vitro and in vivo by targeting ccnd1.
Ren Y; Li Y; Zhang W; Yang K; Li J; Hu Y; Zuo Z; Xu C; Pan Y; Zhang X
Biochem Biophys Res Commun; 2022 Feb; 594():153-160. PubMed ID: 35085892
[TBL] [Abstract] [Full Text] [Related]
8. hsa‑miR‑15a‑5p inhibits colon cell carcinoma via targeting ccnd1.
Li Z; Zhu Z; Wang Y; Wang Y; Li W; Wang Z; Zhou X; Bao Y
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414457
[TBL] [Abstract] [Full Text] [Related]
9. Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal cancer.
Eraslan E; Adas YG; Yildiz F; Gulesen AI; Karacin C; Arslan UY
J Coll Physicians Surg Pak; 2021 Apr; 31(4):399-404. PubMed ID: 33866724
[TBL] [Abstract] [Full Text] [Related]
10. Clinical characteristics and prognostic factors of colorectal cancer patients with ovarian metastasis: a multicenter retrospective study.
Li X; Zhang W; Ding P; Guo R; Hong Z; Liu P; Wang Z; Yu Y; Fang C; Meng W; Zhang R; Qiu M
Int J Colorectal Dis; 2021 Jun; 36(6):1201-1208. PubMed ID: 33511478
[TBL] [Abstract] [Full Text] [Related]
11. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
[TBL] [Abstract] [Full Text] [Related]
12. MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy.
Jang JK; Choi SH; Park SH; Kim KW; Kim HJ; Lee JS; Kim AY
Eur Radiol; 2020 Apr; 30(4):2312-2323. PubMed ID: 31953656
[TBL] [Abstract] [Full Text] [Related]
13. Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for colorectal Carcinoma.
Angius A; Uva P; Pira G; Muroni MR; Sotgiu G; Saderi L; Uleri E; Caocci M; Ibba G; Cesaraccio MR; Serra C; Carru C; Manca A; Sanges F; Porcu A; Dolei A; Scanu AM; Rocca PC; De Miglio MR
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434359
[TBL] [Abstract] [Full Text] [Related]
14. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer.
Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
J Geriatr Oncol; 2019 Sep; 10(5):705-708. PubMed ID: 30795923
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Prognostic Biomarker Signatures and Candidate Drugs in colorectal cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract] [Full Text] [Related]
16. Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer.
Hwang JA; Kim YK; Min JH; Song KD; Sohn I; Ahn HS
Acta Radiol; 2019 Apr; 60(4):441-450. PubMed ID: 30130970
[TBL] [Abstract] [Full Text] [Related]
17. Competing endogenous RNA network crosstalk reveals novel molecular markers in colorectal cancer.
Samir N; Matboli M; El-Tayeb H; El-Tawdi A; Hassan MK; Waly A; El-Akkad HAE; Ramadan MG; Al-Belkini TN; El-Khamisy S; El-Asmar F
J Cell Biochem; 2018 Aug; 119(8):6869-6881. PubMed ID: 29737552
[TBL] [Abstract] [Full Text] [Related]
18. Prevalence of Synchronous Oligopolyposis in Incident colorectal cancer: A Population-Based Study.
Marqués-Lespier JM; Soto-Salgado M; González-Pons M; Méndez V; Freyre K; Beltrán C; Pericchi LR; Cruz-Correa M
P R Health Sci J; 2018 Mar; 37(1):39-45. PubMed ID: 29547683
[TBL] [Abstract] [Full Text] [Related]
19. MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.
Yau TO; Wu CW; Tang CM; Chen Y; Fang J; Dong Y; Liang Q; Ng SS; Chan FK; Sung JJ; Yu J
Oncotarget; 2016 Jan; 7(2):1559-68. PubMed ID: 26621842
[TBL] [Abstract] [Full Text] [Related]
20. In-depth analysis of the critical genes and pathways in colorectal cancer.
Liu F; Ji F; Ji Y; Jiang Y; Sun X; Lu Y; Zhang L; Han Y; Liu X
Int J Mol Med; 2015 Oct; 36(4):923-30. PubMed ID: 26239303
[TBL] [Abstract] [Full Text] [Related]
[Next]
